Oral mucosal graft ureteroplasty versus ileal ureteric replacement: a meta‐analysis

Author:

You Yongqiang1,Gao Xincheng1,Chai Shuaishuai1,Chen Jiawei1ORCID,Wang Jianli1,Zhang Hao1,Zhou Yuancheng1,Yu Zehao1,Cheng Gong1,Li Bing1ORCID,Xiao Xingyuan1

Affiliation:

1. Department of Urology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

Abstract

ObjectivesTo describe outcomes of oral mucosal graft ureteroplasty (OMGU) and ileal ureter replacement (IUR) and determine the relative merits of both procedures.MethodsDatabases (including PubMed, Embase and Cochrane) were interrogated for eligible trials that assessed outcomes of OMGU or IUR from 2000 to 30 July 2022. The variables analysed were reconstruction success rates, stricture length, hospital stays, perioperative complications and long‐term complications.ResultsA total of 23 single‐arm studies were included. The pooled reconstruction success rates for OMGU and IUR were 94.9% (95% confidence interval [CI] 91.0%–97.7%) and 85.8% (95% CI 81.0%–90.0%), respectively. Stricture length of patients in the OMGU and IUR groups were 3.73 (95% CI 3.17–4.28) and 11.55 (95% CI 9.82–13.29) cm, respectively. The maximal stricture length repaired by OMGU was 8 cm. The hospital stays were 5.85 (95% CI 3.88–7.82) and 11.55 (95% CI 6.93–16.17) days in the OMGU and IUR groups, respectively. The incidences of low‐grade postoperative complications were 13.6% (95% CI 6.9%–20.3%) and 27.3% (95% CI 19.5%–35.1%), high‐grade postoperative complications were 4.6% (95% CI 1.8I–8.5%) and 13.0% (95% CI 9.4%–17.1%), and long‐term complications (occurred at > 3months) were 9.0% (95% CI 1.7%–20.0%) and 35.4% (95% CI 25.8%–45.6%) in the OMGU and IUR groups, respectively.ConclusionAn OMGU is an effective, minimally invasive, and safe alternative to IUR for the management of long ureteric strictures. OMGU was the preferred treatment for long ureteric strictures, especially obstructed ureter segments of ≤8 cm.

Publisher

Wiley

Subject

Urology

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3